跳至主要内容
临床试验/NCT00798616
NCT00798616撤回不适用

Are Steroids Efficacious in Hospitalized Patients With Bronchiolitis Who Show an Objective Clinical Improvement After Albuterol ("Albuterol Responders")?

University Hospitals Cleveland Medical Center1 个研究点 分布在 1 个国家开始时间: 2008年11月26日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
length of hospitalization (actual and until meets "ready for discharge" criteria)

研究概览

简要总结

The purpose of the study is to determine whether corticosteroids are beneficial to children with bronchiolitis whose breathing gets better after being given a breathing treatment with albuterol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
4 Weeks 至 24 Months(Child)
性别
All
接受健康志愿者

入选标准

  • diagnosis of bronchiolitis
  • Respiratory Distress Assessment Index score of 4 or more

排除标准

  • prior prescription of bronchodilators or inhaled corticosteroids
  • birth at <36 weeks gestation
  • chronic cardiac disease
  • chronic pulmonary disease (including asthma)
  • immunodeficiency
  • non-topical steroid use in the prior week
  • parents that don't understand English
  • baseline systolic blood pressure >118 mmHg
  • home oxygen use
  • evidence of systemic fungal or varicella infection
  • bronchodilator use in the prior week
  • allergy to albuterol or corticosteroids

研究组 & 干预措施

Responders/Placebo

Placebo Comparator

Albuterol responders being given placebo

干预措施: placebo (Drug)

Responders/Steroids

Active Comparator

albuterol responders being given steroids

干预措施: prednisolone or methylprednisolone (Drug)

Non-responders/placebo

Placebo Comparator

non-albuterol responders being given placebo

干预措施: placebo (Drug)

non-responders/steroids

Active Comparator

non-albuterol responders being given steroids

干预措施: prednisolone or methylprednisolone (Drug)

结局指标

主要结局

length of hospitalization (actual and until meets "ready for discharge" criteria)

时间窗: variable, likely no more than 2 weeks

respiratory rate and respiratory distress score

时间窗: 4 hours

次要结局

  • need for increased respiratory support (intubation, CPAP, BiPAP)(variable, likely up to 2 weeks)
  • amount of oxygen used during hospitalization(variable, likely less than 2 weeks)
  • total duration of symptoms(variable, likely no more than 3 weeks)
  • need for unanticipated medical care after discharge(variable, likely no more than 3 weeks)
  • tachycardia and/or hypertension during hospitalization(variable, likely no more than 2 weeks)
  • number of doses of bronchodilators used during hospitalization(variable, likely no more than 2 weeks)

研究者

研究点 (1)

Loading locations...

相似试验